Cheng HL - Search Results

1

SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor.

Chiang CY, Pan CC, Chang HY, Lai MD, Tzai TS, Tsai YS, Ling P, Liu HS, Lee BF, Cheng HL, Ho CL, Chen SH, Chow NH. Chiang CY, et al. Among authors: cheng hl. Clin Cancer Res. 2015 Dec 15;21(24):5601-11. doi: 10.1158/1078-0432.CCR-14-3308. Epub 2015 Aug 18. Clin Cancer Res. 2015. PMID: 26286913

2

Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON.

Chang HY, Liu HS, Lai MD, Tsai YS, Tzai TS, Cheng HL, Chow NH. Chang HY, et al. Among authors: cheng hl. Cancer Res. 2014 Aug 15;74(16):4549-62. doi: 10.1158/0008-5472.CAN-13-3730. Epub 2014 Jun 5. Cancer Res. 2014. PMID: 24903148

3

Urothelial carcinoma with trophoblastic differentiation: Reappraisal of the clinical implication and immunohistochemically features.

Cheng HL, Chou LP, Tsai HW, Lee CT, Wang YW, Chung-Liang H, Ou JH, Tsai YS, Chow NH. Cheng HL, et al. Urol Oncol. 2021 Oct;39(10):732.e17-732.e23. doi: 10.1016/j.urolonc.2021.03.006. Epub 2021 Mar 26. Urol Oncol. 2021. PMID: 33773916

4

Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer.

Chow NH, Liu HS, Lee EI, Chang CJ, Chan SH, Cheng HL, Tzai TS, Lin JS. Chow NH, et al. Among authors: cheng hl. Anticancer Res. 1997 Mar-Apr;17(2B):1293-6. Anticancer Res. 1997. PMID: 9137488

5

Expression of vascular endothelial growth factor in primary superficial bladder cancer.

Chow NH, Liu HS, Chan SH, Cheng HL, Tzai TS. Chow NH, et al. Among authors: cheng hl. Anticancer Res. 1999 Sep-Oct;19(5C):4593-7. Anticancer Res. 1999. PMID: 10650816

6

EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer.

Wang YW, Cheng HL, Ding YR, Chou LH, Chow NH. Wang YW, et al. Among authors: cheng hl. Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):199-211. doi: 10.1016/j.bbcan.2017.04.004. Epub 2017 Apr 10. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28408326 Review.

7

Urinary cytodiagnosis: can it have a different prognostic implication than a diagnostic test?

Chow NH, Tzai TS, Cheng HL, Chan SH, Lin JS. Chow NH, et al. Among authors: cheng hl. Urol Int. 1994;53(1):18-23. doi: 10.1159/000282625. Urol Int. 1994. PMID: 7974880

8

Near-diploid transitional cell carcinoma: a preliminary report.

Chow NH, Tzai TS, Lin SN, Su WC, Cheng HL. Chow NH, et al. Among authors: cheng hl. Int Urol Nephrol. 1994;26(4):423-30. doi: 10.1007/BF02768013. Int Urol Nephrol. 1994. PMID: 8002215

9

Significance of urinary tissue polypeptide specific antigen (TPS) determination in patients with urothelial carcinoma.

Yao WJ, Chang CJ, Chan SH, Chow NH, Cheng HL, Tzai TS, Lin SN. Yao WJ, et al. Among authors: cheng hl. Anticancer Res. 1995 Nov-Dec;15(6B):2819-23. Anticancer Res. 1995. PMID: 8669871

10

Prognostic significance of proliferating cell nuclear antigen expression in transitional cell carcinoma of the upper urinary tract.

Cheng HL, Chow NH, Tzai TS, Tong YC, Lin JS, Chan SH, Yang WH, Chang CC, Lin YM. Cheng HL, et al. Anticancer Res. 1997 Jul-Aug;17(4A):2789-93. Anticancer Res. 1997. PMID: 9252716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

601 results

Search Page

Filters